The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.
Capable of giving signed informed consent and comply with the requirements listed in the Informed Consent Form.
Willing and able to follow all instructions and attend all study visits.
History of redness relief eyedrop use within the last 6 months, or an interest in using over-the-counter redness relief drops, or would benefit from the use of redness relief drops in the investigator's opinion.
Baseline ocular redness score greater than 1 unit on a 5-point scale in both eyes prior to randomization.
Known contraindications or sensitivity to the use of any of the study treatment(s) or their components, or any other medication required by the protocol.
Ocular surgical interventions within 6 months prior to Visit 1 or during the study.
Any ocular condition that, in the opinion of the investigator, may compromise the subject's safety or study parameters.
Use of prohibited medications, devices, or treatments as specified in the protocol.